Shuli Kulak

Shuli Kulak MD, MBA has a diverse work experience in the biomedical field. They have held positions at various companies, starting with their current role as Head of Corporate Strategy and BD at Solid Biosciences since 2022. Prior to that, they served as a Venture Partner at Deep Science Ventures starting in 2020.

In 2021, Dr. Kulak joined AavantiBio, Inc. as the Head of Corporate Strategy & BD, and stayed until early 2023. Before that, they worked at Lonza as the Head of Strategy from 2019 to 2021.

Dr. Kulak gained experience in corporate strategy and business development at BioMarin Pharmaceutical Inc. as the Director of Corporate Strategy and Business Development from 2018 to 2020. They also worked as the Director of New Business Development-Rare Pediatric Diseases at Fortress Biotech from 2016 to 2018.

Prior to their roles in the industry, Dr. Kulak worked as a physician at Montefiore Medical Center from 2012 to 2016. Additionally, they served as an IRB Administrator at Albert Einstein College of Medicine in 2005 and 2006.

Throughout their career, Dr. Kulak has demonstrated expertise in corporate strategy, business development, and biomedical research.

Shuli Kulak MD, MBA began their education at Yeshiva University in 2002, where they pursued a Bachelor of Arts (B.A.) degree with a minor in Business. Their field of study during this time was Biology/Biological Sciences, General. They completed their undergraduate studies in 2005.

In 2008, Kulak enrolled at the Albert Einstein College of Medicine, where they obtained a Doctor of Medicine (M.D.) degree. They spent four years at this institution, completing their medical education in 2012.

After a few years in the medical field, Kulak decided to pursue further education in business. From 2014 to 2016, they attended the Sy Syms School of Business, where they earned a Master of Business Administration (MBA) degree. The field of study for the MBA degree is not specified.

No information is provided about any additional certifications received by Shuli Kulak.